Cazeaux Nicolas, Bennasser Yamina, Vidal Pierre-Louis, Li Zhenlin, Paulin Denise, Bahraoui Elmostafa
Université Paul Sabatier, EA 3038, Laboratoire d'Immuno-Virologie, 118 Route de Narbonne, 31062 Toulouse Cedex, France.
Vaccine. 2002 Sep 10;20(27-28):3322-31. doi: 10.1016/s0264-410x(02)00310-9.
The objective of this study was to compare immune responses induced against HIV-1 Nef after DNA immunization with Nef encoding plasmids under the control of an ubiquitous or a muscle-specific promoter. To this end, plasmids containing HIV-1 nef under the control of the Cytomegalovirus or the human desmin promoters, specifically expressed in muscle cells, were constructed. Different groups of BALB/c mice were immunized with 10 or 100 microg of both constructs, controls were the pcDNA3 vector or the Nef protein in Freund's adjuvant (Nef-CFA). Our data showed that both plasmids stimulated anti-Nef humoral responses in a dose-dependent manner. The anti-Nef antibody response, however, was earlier and higher with the CMV-IE promoter than with the desmin promoter. We also showed that Nef expressing plasmids induced high titers of anti-Nef antibodies (10(4)), comparable to those obtained in the Nef-CFA group (4x10(4)). Analysis of the specificity of anti-Nef antibodies revealed no influence of the promoter, and in contrast to Nef-CFA, plasmid immunization elicited anti-Nef antibodies directed principally against conformational-dependent epitopes. Data on the lymphoproliferative response showed that the specificity of expression, or the plasmid dose, did not affect the onset-time or the intensity of the response. The predominant IgG2a isotype of anti-Nef antibodies and the cytokine profile, mostly IL-2 and IFN-gamma, produced by Nef-stimulated spleen cells indicated a Th1 response in plasmid-immunized mice, in contrast to mice immunized with Nef-CFA, where a Th2 response was induced. In conclusion, these data indicate that antigen expression by muscle cells is sufficient to stimulate a Th1 immune response.
本研究的目的是比较在普遍存在或肌肉特异性启动子控制下,用编码Nef的质粒进行DNA免疫后诱导的针对HIV-1 Nef的免疫反应。为此,构建了在巨细胞病毒或人结蛋白启动子(在肌肉细胞中特异性表达)控制下含有HIV-1 nef的质粒。不同组的BALB/c小鼠用10或100微克的两种构建体进行免疫,对照组为pcDNA3载体或弗氏佐剂中的Nef蛋白(Nef-CFA)。我们的数据表明,两种质粒均以剂量依赖方式刺激抗Nef体液反应。然而,与结蛋白启动子相比,CMV-IE启动子诱导的抗Nef抗体反应更早且更强。我们还表明,表达Nef的质粒诱导出高滴度的抗Nef抗体(10⁴),与Nef-CFA组获得的滴度(4×10⁴)相当。抗Nef抗体特异性分析显示启动子没有影响,与Nef-CFA相反,质粒免疫引发的抗Nef抗体主要针对构象依赖性表位。淋巴细胞增殖反应数据表明,表达特异性或质粒剂量不影响反应的起始时间或强度。抗Nef抗体的主要IgG2a亚型以及Nef刺激的脾细胞产生的细胞因子谱(主要是IL-2和IFN-γ)表明,质粒免疫的小鼠中有Th1反应,这与用Nef-CFA免疫的小鼠相反,后者诱导的是Th2反应。总之,这些数据表明肌肉细胞中的抗原表达足以刺激Th1免疫反应。